$2.56 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 127 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HCA | HCA HOLDINGS INCcall | $18,144,000 | +20.6% | 200,000 | 0.0% | 0.71% | +11.1% | |
THC | TENET HEALTHCARE CORPcall | $11,576,000 | +16.9% | 200,000 | 0.0% | 0.45% | +7.9% | |
LIBERTY MEDIA CORPdeb 4.000%11/1 | $8,004,000 | -4.6% | 13,000,000 | 0.0% | 0.31% | -12.1% | ||
OAK | OAKTREE CAP GROUP LLCunit cl a | $7,677,000 | +3.0% | 144,350 | 0.0% | 0.30% | -5.1% | |
UPIP | UNWIRED PLANET INC NEW | $4,055,000 | +8.4% | 6,540,246 | 0.0% | 0.16% | 0.0% | |
ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $1,771,000 | -1.1% | 1,750,000 | 0.0% | 0.07% | -9.2% | ||
CIVI | CIVITAS SOLUTIONS INC | $1,579,000 | +1.8% | 74,050 | 0.0% | 0.06% | -6.1% | |
AAL | AMERICAN AIRLS GROUP INC | $608,000 | -34.1% | 450,000 | 0.0% | 0.02% | -38.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
ISHARES TR | 27 | Q3 2023 | 13.2% |
HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
AMAZON COM INC | 18 | Q3 2022 | 7.6% |
SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G | 2024-04-15 |
13F-HR/A | 2024-03-18 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2023-11-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.